Stay updated on Magrolimab in Hematological Malignancies Clinical Trial

Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of medical and healthcare-related publications and documentation.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:23.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for study participants, including specific health conditions and prior treatments required for inclusion. Previously, this section had no information provided.
    Difference
    20%
    Check dated 2024-05-22T20:29:21.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:36:11.000Z thumbnail image

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.